When something sounds too good to be true, unfortunately it generally is. At least that seems the case for POM Wonderful this week. The ubiquitous curvy bottled pomegranate juice drink, which claims potential prevention and treatment of heart disease, reduction in the risk of prostate cancer and overcoming erectile dysfunction, is under fire by the Federal Trade Commission. The FTC believes POM’s evidence doesn’t support their remarkable health claims. On Monday, they charged POM Wonderful and the company’s owners (philanthropists Lynda and Stewart Resnick) with making misleading and unsubstantiated declarations about the abilities of their pomegranate solution.
The company alleges to have spent $34 million on pomegranate research, including 19 clinical trials and multiple studies published in peer-reviewed journals. While the commission does not dispute that the company’s medical studies exist, they believe the advertising claims overstate the results and ignore Continue reading